TY - JOUR
T1 - The relationship between serum IgE and surface levels of FcεR on human leukocytes in various diseases
T2 - Correlation of expression with FcεRI on basophils but not on monocytes or eosinophils
AU - Saini, Sarbjit S.
AU - Klion, Amy D.
AU - Holland, Steven M.
AU - Hamilton, Robert G.
AU - Bochner, Bruce S.
AU - MacGlashan, Donald W.
N1 - Funding Information:
Supported in part by National Institutes of Health grants AI42220, AI07290, and AI01564; an American Lung Association Research Grant; and a Johns Hopkins Clinician Scientist Award.
PY - 2000
Y1 - 2000
N2 - Background: Expression of receptors for IgE (FcεR) have been mainly studied on mast cells and blood basophils in the context of allergic disease. Some reports have noted limited expression of FcεR on other leukocytes, including blood monocytes and eosinophils in certain patients. An association between human blood basophil expression of FcεRIα and serum IgE has been noted among allergic subjects. Objective: Recent evidence supports regulation of FcεRIα by free IgE on both mast cells and basophils. We hypothesized that this relationship would exist across an extremely wide range of IgE levels for human basophils, irrespective of underlying disease. We further examined whether a similar relationship existed between serum IgE and FcεRIα or FcεRII (CD23) expression on monocytes and eosinophils in these same subjects. Methods: Blood was obtained from nonallergic subjects (n = 3) and subjects with allergic asthma (n = 5), atopic dermatitis (n = 3), hypereosinophilic syndromes (n = 7), hyper-IgE syndrome (n = 6), helminth infestation (n = 6), or IgE myeloma (n = 1). Levels of serum IgE were determined by using RIA and ranged from 3 to 4.7 mg/mL. Levels of cell surface FcεRIα, FcεRII, and IgE were measured by using immunofluorescence and flow cytometry. Results: Basophil surface IgE density and FcεRIα expression correlated with serum IgE levels (r = 0.67 and r = 0.46, respectively; P < .01; n = 31) regardless of the disease state. In contrast, monocyte FcεRIα expression did not correlate with serum IgE (r = 0.09, P > .5, n = 29), and low-level eosinophil FcεRIα expression was only detected in a single asthmatic subject. CD23 expression was not detected on basophils or eosinophils, except for the eosinophils from the donor with IgE myeloma. CD23 was present on monocytes from some donors but did not correlate with serum IgE levels. Conclusions: In a variety of disease states, FcεRIα expression by basophils, but not monocytes or eosinophils, correlated with serum IgE levels across a 6-log range of IgE. These data support the concept of in vivo regulation of FcεRIα on basophils by serum IgE and further demonstrate that this is independent of allergic disease per se.
AB - Background: Expression of receptors for IgE (FcεR) have been mainly studied on mast cells and blood basophils in the context of allergic disease. Some reports have noted limited expression of FcεR on other leukocytes, including blood monocytes and eosinophils in certain patients. An association between human blood basophil expression of FcεRIα and serum IgE has been noted among allergic subjects. Objective: Recent evidence supports regulation of FcεRIα by free IgE on both mast cells and basophils. We hypothesized that this relationship would exist across an extremely wide range of IgE levels for human basophils, irrespective of underlying disease. We further examined whether a similar relationship existed between serum IgE and FcεRIα or FcεRII (CD23) expression on monocytes and eosinophils in these same subjects. Methods: Blood was obtained from nonallergic subjects (n = 3) and subjects with allergic asthma (n = 5), atopic dermatitis (n = 3), hypereosinophilic syndromes (n = 7), hyper-IgE syndrome (n = 6), helminth infestation (n = 6), or IgE myeloma (n = 1). Levels of serum IgE were determined by using RIA and ranged from 3 to 4.7 mg/mL. Levels of cell surface FcεRIα, FcεRII, and IgE were measured by using immunofluorescence and flow cytometry. Results: Basophil surface IgE density and FcεRIα expression correlated with serum IgE levels (r = 0.67 and r = 0.46, respectively; P < .01; n = 31) regardless of the disease state. In contrast, monocyte FcεRIα expression did not correlate with serum IgE (r = 0.09, P > .5, n = 29), and low-level eosinophil FcεRIα expression was only detected in a single asthmatic subject. CD23 expression was not detected on basophils or eosinophils, except for the eosinophils from the donor with IgE myeloma. CD23 was present on monocytes from some donors but did not correlate with serum IgE levels. Conclusions: In a variety of disease states, FcεRIα expression by basophils, but not monocytes or eosinophils, correlated with serum IgE levels across a 6-log range of IgE. These data support the concept of in vivo regulation of FcεRIα on basophils by serum IgE and further demonstrate that this is independent of allergic disease per se.
KW - Basophils
KW - Eosinophils
KW - IgE antibody
KW - IgE receptors
KW - Monocytes
UR - http://www.scopus.com/inward/record.url?scp=0034502211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034502211&partnerID=8YFLogxK
U2 - 10.1067/mai.2000.108431
DO - 10.1067/mai.2000.108431
M3 - Article
C2 - 10984372
AN - SCOPUS:0034502211
SN - 0091-6749
VL - 106
SP - 514
EP - 520
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 3
ER -